Virax Biolabs Group Limited (VRAX)

NASDAQ: VRAX · IEX Real-Time Price · USD

0.700

+0.049 (7.53%)

At close: Apr 25, 2024, 3:05 PM

0.717

+0.017 (2.46%)

After-hours: Apr 25, 2024, 7:20 PM EDT

Virax Biolabs Group Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	2022	2021	2020	2019
Net Income	-5.46	-1.71	-0.65	-0.71
Share-Based Compensation	1.75	0.29	0	0
Other Operating Activities	-0.48	0.61	0.06	-0.03
Operating Cash Flow	-4.18	-0.81	-0.59	-0.74
Capital Expenditures	-0.18	0	0	0
Investing Cash Flow	-0.18	0	0	0
Share Issuance / Repurchase	13.65	0.52	0.4	0
Debt Issued / Paid	0.03	0.29	0.18	0.7
Financing Cash Flow	13.69	0.81	0.59	0.7
Net Cash Flow	9.33	0	-0	-0.04
Free Cash Flow	-4.36	-0.81	-0.59	-0.74
Free Cash Flow Margin	-50907.25%	-	-476.65%	-745.54%
Free Cash Flow Per Share	-4.10	-0.85	-2.45	-7.13

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).